Ipg Photonics earnings release, May 5, 2026

Ipg Photonics Corp (IPGP) · Form 8-K, Item 2.02 · Filed · SEC filing

IPG PHOTONICS ANNOUNCES FIRST QUARTER 2026 FINANCIAL RESULTS

Strong Start to the Year on Growing Demand and Continued Focus on Execution of Strategic Initiatives

Managing Costs and Mitigating Tariff Impact on Gross Margin

MARLBOROUGH, Mass. – May 5, 2026 -

IPG Photonics Corporation

(NASDAQ: IPGP) today reported financial results for the first quarter ended March 31, 2026.

*Adjusted gross margin, adjusted EBITDA and adjusted earnings per diluted share include non-GAAP adjustments. A reconciliation from GAAP to non-GAAP metrics is provided in this earnings release.

NM - not meaningful.

Management Comments

“I am pleased to share that first-quarter revenue came in above our expectations. The team delivered our second consecutive quarter of double-digit year-over-year revenue growth, driven by disciplined execution of our key strategic initiatives and continued strong demand for our laser solutions,” said Dr. Mark Gitin, Chief Executive Officer of IPG Photonics.

Financial Highlights

Beginning in the first quarter, the Company revised its revenue disaggregation by application into two categories: Industrial Solutions and Advanced Solutions. This structure better reflects the Company's strategic growth initiatives and provides a clearer separation between the Company's industrial and non-industrial businesses, giving better visibility into the distinct performance and growth profiles of each.¹

Exhibit 99.1

First quarter revenue of $265 million increased 17% year over year, driven by growth in Industrial Solutions. Changes in foreign exchange rates increased revenue growth by approximately 4%. Industrial Solutions sales accounted for 86% of total revenue and increased 21% year over year, driven by growth in welding, cutting, marking, and cleaning applications. Advanced Solutions sales decreased 5% year over year due to lower revenue in micromachining and defense applications, partially offset by increased sales in medical and semiconductor applications. Emerging growth products accounted for 53% of total revenue, consistent with the prior quarter. By region, sales increased 14% in Asia, 27% in North America, and 4% in Europe on a year-over-year basis.

GAAP gross margin of 37.5% and adjusted gross margin of 37.8% decreased year over year due to tariffs and higher product cost, partially offset by lower inventory provisions. Adjusted EBITDA was $35.2 million and adjusted earnings per diluted share (EPS) was $0.29 in the first quarter. During the first quarter, IPG spent $16 million on capital expenditures.

Business Outlook and Financial Guidance

“Our book-to-bill was once again firmly above one in the first quarter, reflecting robust demand for our solutions despite elevated macroeconomic uncertainty. We remain focused on executing on our growth strategy supported by operational excellence and an innovation engine that is unlocking areas of significant additional opportunities. This foundation gives us confidence in our ability to achieve above-market growth and deliver lasting value for our customers and shareholders.” concluded Dr. Gitin.

For the second quarter of 2026, IPG expects revenue of $260 million to $290 million, adjusted gross margin between 37% and 40% and adjusted operating expenses of $92 million to $95 million. IPG anticipates delivering adjusted earnings per diluted share in the range of $0.25 to $0.55 and adjusted EBITDA in the range of $32 million to $48 million.

As discussed in more detail in the "Safe Harbor" passage of this news release, actual results may differ from this guidance due to various factors including, but not limited to, trade policy changes and trade restrictions, product demand, order cancellations and delays, competition, tariffs and retaliatory tariffs, currency fluctuations and general economic conditions. The current uncertainty related to the trade environment and tariff policies increases the risks to the outlook that we have provided. This guidance is based upon current market conditions and expectations, and is subject to the risks outlined in the Company's reports filed with the SEC, and assumes exchange rates relative to the U.S. dollar of euro 0.87, Japanese yen 159 and Chinese yuan 6.92, respectively.

Supplemental Financial Information

Additional supplemental financial information is provided in the unaudited Financial Data Workbook and First Quarter 2026 Earnings Call Presentation available on the investor relations section of the Company's website at investor.ipgphotonics.com.

Conference Call Reminder

The Company will hold a conference call today, May 5, 2026 at 10:00 am ET. To access the call, please dial 877-407-6184 in the US or 201-389-0877 internationally. A live webcast of the call will also be available and archived on the investor relations section of the Company's website at investor.ipgphotonics.com.

Contact

Eugene Fedotoff

Senior Director, Investor Relations

IPG Photonics Corporation

508-597-4713 efedotoff@ipgphotonics.com

About IPG Photonics Corporation

IPG Photonics Corporation is the leader in high-power fiber lasers and amplifiers used primarily in materials processing and other diverse applications. The Company’s mission is to develop innovative laser solutions, making the world a better place. IPG accomplishes this mission by delivering superior performance, reliability, and usability at a lower total cost of ownership compared with other types of lasers and non-laser tools, allowing end users to increase productivity and decrease costs. IPG is headquartered in Marlborough, Massachusetts and has more than 30 facilities worldwide. For more information, visit www.ipgphotonics.com.²

Exhibit 99.1

Financial statements

Income Statement

Three Months Ended March 31, — (NASDAQ: IPGP) today reported financial results for the first quarter ended March 31, 2026. (In millions, except per share data and percentages)

Three Months Ended March 31, – 2026Three Months Ended March 31, – 2025Three Months Ended March 31, – Change
Revenue265.5227.817
Gross margin37.5%39.4%
Operating income (loss)-7.71.8NM
Operating margin-2.9%0.8%
Net income1.63.8-58
Earnings per diluted share0.040.09-56
Non-GAAP Measures*Adjusted gross margin37.8%40.0%
Non-GAAP Measures*Adjusted EBITDA35.232.78
Non-GAAP Measures*Adjusted earnings per diluted share0.290.31-6

Income Statement

Three Months Ended March 31, — (UNAUDITED) (In thousands, except per share data)

Three Months Ended March 31, – 2026Three Months Ended March 31, – 2025
Net sales265,497227,793
Cost of sales165,998137,981
Gross profit99,49989,812
Operating expenses:Sales and marketing24,53424,430
Operating expenses:Research and development33,30928,336
Operating expenses:General and administrative36,09232,808
Operating expenses:Settlement of litigation matters13,500
Operating expenses:(Gain) loss on foreign exchange-2002,411
Operating expenses:Total operating expenses107,23587,985
Operating expenses:Operating (loss) income-7,7361,827
Other income, net:Interest income, net6,9227,444
Other income, net:Other income, net1,8331,344
Other income, net:Total other income8,7558,788
Other income, net:Income before provision for income taxes1,01910,615
Other income, net:(Benefit) provision for income taxes-5656,857
Other income, net:Net income1,5843,758
Net income per common share:Basic0.040.09
Net income per common share:Diluted0.040.09
Weighted average common shares outstanding:Basic42,24542,605
Weighted average common shares outstanding:Diluted42,91242,832

Income Statement

Three Months Ended March 31, — Reconciliation of Gross Profit to Adjusted Gross Profit, Adjusted Gross Margin (in thousands, except percentages)

Three Months Ended March 31, – 2026Three Months Ended March 31, – 2025
Gross profit99,49989,812
Gross margin37.5%39.4%
Amortization of acquisition-related intangibles8521,016
Acquisition and integration charges222
Adjusted gross profit100,35191,050
Adjusted gross margin37.8%40.0%

Income Statement

Three Months Ended March 31, — Reconciliation of Operating income (loss) to Adjusted Operating Income (in thousands)

Three Months Ended March 31, – 2026Three Months Ended March 31, – 2025
Operating (loss) income-7,7361,827
Amortization of acquisition-related intangibles2,0892,502
Restructuring charges66
Acquisition and integration charges906991
Settlement and fees of litigation matters14,128
(Gain) loss on foreign exchange-2002,411
Adjusted operating income9,2537,731

Income Statement

Three Months Ended March 31, — Reconciliation of Net income to Adjusted EBITDA (in thousands)

Three Months Ended March 31, – 2026Three Months Ended March 31, – 2025
Net income1,5843,758
Interest income, net-6,922-7,444
Provision for income taxes-5656,857
Depreciation12,74711,556
Amortization3,1453,785
EBITDA9,98918,512
Stock based compensation10,34110,767
Restructuring charges66
Acquisition and integration charges906991
Settlement and fees of litigation matters14,128
(Gain) loss on foreign exchange-2002,411
Adjusted EBITDA35,23032,681

Income Statement

Three Months Ended March 31, — Reconciliation of GAAP to Non-GAAP Net Income, and GAAP to Non-GAAP Net Income per Share, Diluted (in thousands, except per share data)

Three Months Ended March 31, – 2026Three Months Ended March 31, – 2025
Net income1,5843,758
Amortization of acquisition-related intangibles2,0892,502
Restructuring charges66
Acquisition and integration charges906991
Settlement and fees of litigation matters14,128
(Gain) loss on foreign exchange-2002,411
Certain discrete tax items-1,1194,614
Tax impact of non-GAAP adjustments-4,873-1,148
Adjusted net income12,58113,128
Adjusted net earnings per diluted share0.290.31
Weighted average diluted shares outstanding42,91242,832

Balance Sheet

December 31, — (UNAUDITED) (In thousands, except share and per share data)

March 31, – 2026 – ASSETSDecember 31, – 2025 – ASSETS
Current assets:Cash and cash equivalents480,761403,790
Current assets:Short-term investments332,144435,538
Current assets:Accounts receivable, net192,437181,734
Current assets:Inventories319,006313,416
Current assets:Prepaid income taxes51,20343,196
Current assets:Prepaid expenses and other current assets57,58745,766
Current assets:Total current assets1,433,1381,423,440
Current assets:Long-term investments70,56776,533
Current assets:Deferred income taxes, net120,934123,889
Current assets:Goodwill70,91371,735
Current assets:Intangible assets, net47,17149,933
Current assets:Property, plant and equipment, net636,242637,516
Current assets:Other assets42,67741,234
Current assets:Total assets2,421,6422,424,280
Current assets:LIABILITIES AND EQUITYLIABILITIES AND EQUITYLIABILITIES AND EQUITY
Current liabilities:Accounts payable54,72439,288
Current liabilities:Accrued expenses and other current liabilities184,849184,849
Current liabilities:Income taxes payable7,6039,900
Current liabilities:Total current liabilities247,176234,037

Cash Flow

Three Months Ended March 31, — (UNAUDITED) (in thousands)

Three Months Ended March 31, – 2026Three Months Ended March 31, – 2025
Cash flows from operating activities:Net income1,5843,758
Adjustments to reconcile net income to net cash (used in) provided by operating activities:Depreciation and amortization15,89215,341
Adjustments to reconcile net income to net cash (used in) provided by operating activities:Provisions for inventory, warranty & bad debt9,34811,876
Adjustments to reconcile net income to net cash (used in) provided by operating activities:Other11,42514,796
Changes in assets and liabilities that (used) provided cash:Accounts receivable and accounts payable5,4381,378
Changes in assets and liabilities that (used) provided cash:Inventories-19,417-8,967
Changes in assets and liabilities that (used) provided cash:Other-29,733-24,737
Changes in assets and liabilities that (used) provided cash:Net cash (used in) provided by operating activities-5,46313,445
Cash flows from investing activities:Purchases of and deposits on property, plant and equipment-16,311-24,818
Cash flows from investing activities:Proceeds from sales of property, plant and equipment812183
Cash flows from investing activities:Purchases of investments-32,870-333,009
Cash flows from investing activities:Proceeds from maturities of investments143,53883,206
Cash flows from investing activities:Other7752
Cash flows from investing activities:Net cash provided by (used in) investing activities95,246-274,386
Cash flows from financing activities:Payments for taxes related to net share settlement of equity awards less proceeds from issuance of common stock under employee stock option plans-11,712-5,775
Cash flows from financing activities:Purchase of treasury stock net of excise tax, at cost105
Cash flows from financing activities:Net cash used in financing activities-11,712-5,670
Cash flows from financing activities:Effect of changes in exchange rates on cash and cash equivalents-1,1009,617
Cash flows from financing activities:Net increase (decrease) in cash and cash equivalents76,971-256,994
Cash flows from financing activities:Cash and cash equivalents — Beginning of period403,790620,040
Cash flows from financing activities:Cash and cash equivalents — End of period480,761363,046
Supplemental disclosures of cash flow information:Cash paid for interest35
Supplemental disclosures of cash flow information:Cash paid for income taxes, net of refunds7,68910,574
Full release

Safe Harbor Statement... (truncated)e not statements of historical fact are forward-looking statements, including those statements related to operational excellence, an innovation engine that is unlocking areas of significant additional opportunities, and the ability to achieve above-market growth and deliver lasting value for our customers and shareholders, and statements related to shares repurchases, revenue, adjusted gross margin and operating expenses outlook, adjusted earnings per diluted share and adjusted EBITDA guidance, including the expected impact of tariffs, and the impact of the U.S. dollar on our guidance for the second quarter of 2026. Factors that could cause actual results to differ materially include risks and uncertainties, including risks associated with the strength or weakness of business conditions in industries and geographic markets that IPG serves, particularly the effect of downturns in the markets IPG serves; uncertainties and adverse changes in the general economic conditions of markets; inability to manage risks associated with international customers and operations; changes in trade controls and tariff policies; IPG's ability to penetrate new applications for fiber lasers and increase market share; the rate of acceptance and penetration of IPG's products; foreign currency fluctuations; high levels of fixed costs from IPG's vertical integration; the appropriateness of IPG's manufacturing capacity for the level of demand; competitive factors, including declining average selling prices; the effect of acquisitions and investments; inventory write-downs; asset impairment charges; intellectual property infringement claims and litigation; interruption in supply of key components; manufacturing risks; government regulations and trade sanctions; and other risks identified in IPG's SEC filings. Readers are encouraged to refer to the risk factors described in IPG's Annual Report on Form 10-K (filed with the SEC on February 23, 2026) and IPG's reports filed with the SEC, as applicable. Actual results, events and performance may differ materially. Readers are cautioned not to rely on the forward-looking statements, which speak only as of the date hereof. IPG undertakes no obligation to update the forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.³

Exhibit 99.1

From SEC EDGAR. Analysis by Pear Digitals from the filing alone. Not investment advice. · Ipg Photonics earnings · Latest earnings · Markdown

Screener

Plans

Premium and Pro coming soon.

Log in

New here?

Join the waitlist

Pear FMV opens to everyone soon. We'll email you when it does.